A detailed history of Woodline Partners LP transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 229,376 shares of LXRX stock, worth $162,856. This represents 0.0% of its overall portfolio holdings.

Number of Shares
229,376
Previous 1,211,924 81.07%
Holding current value
$162,856
Previous $1.9 Million 91.11%
% of portfolio
0.0%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$0.65 - $2.08 $638,656 - $2.04 Million
-982,548 Reduced 81.07%
229,376 $169,000
Q3 2024

Nov 14, 2024

BUY
$1.51 - $2.39 $1.83 Million - $2.9 Million
1,211,924 New
1,211,924 $1.9 Million

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $134M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.